Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
Saved in:
| Title: | Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. |
|---|---|
| Authors: | Yarur, Andres J1 (AUTHOR) ajyarur@gmail.com, Chiorean, Michael V2 (AUTHOR), Panés, Julián3 (AUTHOR), Jairath, Vipul4 (AUTHOR), Zhang, Jinkun5 (AUTHOR), Rabbat, Christopher J5 (AUTHOR), Sandborn, William J6 (AUTHOR), Vermeire, Séverine7 (AUTHOR), Peyrin-Biroulet, Laurent8,9 (AUTHOR) |
| Source: | Journal of Crohn's & Colitis. Jun2024, Vol. 18 Issue 6, p885-894. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 18739946 |
|---|---|
| DOI: | 10.1093/ecco-jcc/jjae007 |
